Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;86(1):109-13.
doi: 10.1038/clpt.2009.39. Epub 2009 Apr 15.

Clinically available pharmacogenomics tests

D A Flockhart  1 , T Skaar, D S Berlin, T E Klein, A T Nguyen
Affiliations
Review

Clinically available pharmacogenomics tests

D A Flockhart et al. Clin Pharmacol Ther. 2009 Jul.

Abstract

The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.

PubMed Disclaimer

References

    1. Birney E, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799–816. - PMC - PubMed
    1. Ng PC, Zhao Q, Levy S, Strausberg RL, Venter JC. Individual genomes instead of race for personalized medicine. Clin. Pharmacol. Ther. 2008;84:306–309. - PubMed
    1. Feero WG, Guttmacher AE, Collins FS. The genome gets personal—almost. JAMA. 2008;299:1351. - PubMed
    1. Epstein RS, et al. Payer perspectives on pharmacogenomics testing and drug development. Pharmacogenomics. 2009;10:149. - PubMed
    1. Obama B. The Genomics and Personalized Medicine Act of 2006. Clin. Adv. Hematol. Oncol. 2007;5:39–40. - PubMed

Publication types